Ginkgo Bioworks (DNA) director Henry Christian O receives 25,000 RSU equity grant

Rhea-AI Filing Summary

HENRY CHRISTIAN O reported acquisition or exercise transactions in this Form 4 filing.

Ginkgo Bioworks Holdings, Inc. director Henry Christian O reported receiving a grant of 25,000 restricted stock units. Each RSU represents a contingent right to receive one share of Class A common stock. The award vests on the earlier of June 11, 2027 or the day before the next annual meeting, if he continues serving as a non-employee director. Following this grant, his reported RSU holdings from this award total 25,000 units.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider HENRY CHRISTIAN O

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	25,000	$0.00	--

Holdings After Transaction: Restricted Stock Units — 25,000 shares (Direct, null)

Footnotes (1)

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date.

Key Figures

RSUs granted: 25,000 units Underlying shares: 25,000 shares Vesting date: June 11, 2027 +2 more

5 metrics

RSUs granted 25,000 units Restricted Stock Units granted on June 11, 2026

Underlying shares 25,000 shares Class A Common Stock underlying the RSUs

Vesting date June 11, 2027 Latest possible vesting date, subject to earlier annual meeting

Price per RSU $0.0000 Grant recorded with no cash exercise price

Holdings after grant 25,000 units Total RSUs reported following this transaction

Key Terms

Restricted Stock Units, Class A Common Stock, Amended and Restated Non-Employee Director Compensation Program, vesting

4 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A Common Stock financial

"one share of the Issuer's Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Amended and Restated Non-Employee Director Compensation Program financial

"In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program"

vesting financial

"the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HENRY CHRISTIAN O

(Last) (First) (Middle)

C/O GINKGO BIOWORKS HOLDINGS, INC.

27 DRYDOCK AVENUE

(Street)

BOSTON MASSACHUSETTS 02210

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ginkgo Bioworks Holdings, Inc. [ DNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/11/2026		A		25,000		(2)	(2)	Class A Common Stock	25,000	(1)	25,000	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

2. In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date.

Remarks:

	/s/ Karen Tepichin, Attorney-in-Fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Ginkgo Bioworks (DNA) director Henry Christian O report?

He reported receiving a grant of 25,000 restricted stock units. These RSUs are a form of equity compensation that can convert into Class A common shares if vesting conditions tied to continued board service are satisfied over time.

How many Ginkgo Bioworks (DNA) RSUs were granted in this Form 4 filing?

The filing shows a grant of 25,000 restricted stock units. Each RSU corresponds to one share of Class A common stock, giving the director potential ownership of 25,000 shares if all vesting requirements are met.

When do the newly granted Ginkgo Bioworks (DNA) RSUs vest?

The RSUs vest on the earlier of June 11, 2027 or the day immediately before the next annual shareholder meeting. Vesting is conditioned on Henry Christian O continuing to serve as a non-employee director through the applicable vesting date.

What does each Ginkgo Bioworks (DNA) restricted stock unit represent?

Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The shares are only delivered if the vesting conditions described in the company’s non-employee director compensation program are fully satisfied.

Is this Ginkgo Bioworks (DNA) Form 4 transaction a market purchase or sale?

No, the transaction is classified as a grant or award acquisition, not a market trade. The Form 4 uses transaction code “A,” indicating equity compensation granted at no cash cost rather than open-market buying or selling of existing shares.

What program governs the Ginkgo Bioworks (DNA) RSU grant to Henry Christian O?

The grant was made under Ginkgo Bioworks’ Amended and Restated Non-Employee Director Compensation Program. This program, effective June 11, 2026, specifies the size, vesting schedule, and service-based conditions for equity awards to non-employee directors.